Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% |
|
+10.27% | -.--% |
04/04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
09/02 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
45.34B | - | |||||
40.42B | ||||||
37.92B | ||||||
31.75B | - | |||||
27.71B |